Project Details
| Status | Active |
|---|---|
| Effective start/end date | 22/01/25 → 21/01/30 |
Clinical Trial Phase
- Phase II
A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects with Small Cell Lung Cancer (SCLC) (DeLLphi-309)
- Arulananda, Surein (Primary Chief Investigator (PCI))
Project: Research